|
AMZN
|
Consumer Cyclical |
Wedbush |
Maintains
|
Outperform
→
Outperform
|
—
|
$2.9T
|
$234.42
|
-0.5%
|
-0.9%
|
-1.4%
|
+0.2%
|
-1.2%
|
+0.5%
|
|
AMZN
|
Consumer Cyclical |
BofA Securities |
Maintains
|
Buy
→
Buy
|
—
|
$2.9T
|
$234.42
|
-0.5%
|
-0.9%
|
-1.4%
|
+0.2%
|
-1.2%
|
+0.5%
|
|
AMZN
|
Consumer Cyclical |
Citizens |
Maintains
|
Market Outperform
→
Market Outperform
|
—
|
$2.9T
|
$234.42
|
-0.5%
|
-0.9%
|
-1.4%
|
+0.2%
|
-1.2%
|
+0.5%
|
|
WMT
|
Consumer Defensive |
Tigress Financial |
Maintains
|
Buy
→
Buy
|
—
|
$1.1T
|
$112.41
|
+0.1%
|
+1.8%
|
+0.4%
|
+0.2%
|
-1.3%
|
+1.3%
|
|
LLY
|
Healthcare |
Guggenheim |
Maintains
|
Buy
→
Buy
|
—
|
$917.2B
|
$1046.12
|
+0.0%
|
-1.2%
|
-1.8%
|
-0.4%
|
-1.3%
|
-1.5%
|
|
MU
|
Technology |
Goldman Sachs |
Maintains
|
Neutral
→
Neutral
|
—
|
$786.1B
|
$239.49
|
-1.3%
|
-2.2%
|
-3.2%
|
+4.7%
|
+4.1%
|
+2.2%
|
|
ASML
|
Technology |
BofA Securities |
Maintains
|
Buy
→
Buy
|
—
|
$602.8B
|
$1108.78
|
+0.1%
|
+2.9%
|
-2.7%
|
-1.0%
|
+1.8%
|
-0.7%
|
|
AMGN
|
Healthcare |
BMO Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$179.7B
|
$338.36
|
+0.6%
|
+2.1%
|
-1.5%
|
-3.0%
|
-2.6%
|
-2.3%
|
|
CRWD
|
Technology |
BMO Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|
|
CRWD
|
Technology |
Wedbush |
Maintains
|
Outperform
→
Outperform
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|
|
CRWD
|
Technology |
DA Davidson |
Maintains
|
Buy
→
Buy
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|
|
CRWD
|
Technology |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|
|
CRWD
|
Technology |
Cantor Fitzgerald |
Maintains
|
Overweight
→
Overweight
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|
|
CRWD
|
Technology |
Scotiabank |
Maintains
|
Sector Outperform
→
Sector Outperform
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|
|
CRWD
|
Technology |
Citizens |
Maintains
|
Market Outperform
→
Market Outperform
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|
|
CRWD
|
Technology |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|
|
CRWD
|
Technology |
BTIG |
Maintains
|
Buy
→
Buy
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|
|
CRWD
|
Technology |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|
|
CRWD
|
Technology |
Evercore ISI |
Maintains
|
In Line
→
In Line
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|
|
CRWD
|
Technology |
Canaccord Genuity |
Maintains
|
Hold
→
Hold
|
—
|
$159.2B
|
$516.55
|
-3.6%
|
+1.5%
|
-2.1%
|
-0.2%
|
+0.6%
|
+0.5%
|